Clarus Therapeutics Holdings, Inc. (CRXTQ)

USD 0.0

(0.0%)

Operating Income Summary of Clarus Therapeutics Holdings, Inc.

  • Clarus Therapeutics Holdings, Inc.'s latest annual operating income in 2021 was -39.73 Million USD , up 15.78% from previous year.
  • Clarus Therapeutics Holdings, Inc.'s latest quarterly operating income in 2022 Q2 was -10.65 Million USD , up 21.38% from previous quarter.
  • Clarus Therapeutics Holdings, Inc. reported an annual operating income of -47.17 Million USD in 2020, down 0.0% from previous year.
  • Clarus Therapeutics Holdings, Inc. reported a quarterly operating income of -13.54 Million USD for 2022 Q1, down 0.0% from previous quarter.
  • Clarus Therapeutics Holdings, Inc. reported a quarterly operating income of -39.73 Million USD for 2021 FY, up 15.78% from previous quarter.

Annual Operating Income Chart of Clarus Therapeutics Holdings, Inc. (2021 - 2020)

Historical Annual Operating Income of Clarus Therapeutics Holdings, Inc. (2021 - 2020)

Year Operating Income Operating Income Growth
2021 -39.73 Million USD 15.78%
2020 -47.17 Million USD 0.0%

Peer Operating Income Comparison of Clarus Therapeutics Holdings, Inc.

Name Operating Income Operating Income Difference
AstraZeneca PLC 8.19 Billion USD 100.485%
Bristol-Myers Squibb Company PFD CONV 2 17.24 Billion USD 100.23%
CSPC Pharmaceutical Group Limited 7.01 Billion USD 100.566%
Novartis AG 9.76 Billion USD 100.407%
PT Kalbe Farma Tbk. 3625.13 Billion USD 100.001%